[View Larger Version of this Image]

Figure S2. Specificity of the anti-AID monoclonal antibodies used. Western blot analysis of extracts from AID^−/− and AID-EGFP knock-in BL2 cell lines using protein G–purified supernatants of hybridomas 4.26.1, 4.18.1, or a mixture of both, together with anti-actin antibody as control.